dr nayan patel glutathione spray About Central Drugs - Central Drugs Unlocking Skin's Potential from the

Important safety warnings seek urgent medical attention if you experience: Severe or persistent abdominal pain, which may radiate to the back this could indicate pancreatitis , a serious but rare risk associated with GLP-1based therapies as a class [16] [17] Right upper quadrant pain, fever, or jaundice these may suggest gallbladder disease , another class-associated risk Signs of dehydration (dizziness, reduced urine output, extreme thirst) resulting from severe vomiting or diarrhoea, which can affect kidney function Pregnancy and breastfeeding: Use of GLP-1based therapies and related investigational agents is not recommended during pregnancy or breastfeeding

PCAC review begins July 2026

For researchers, the future steps are bigger studies, standard metrics, and more well-matched patient cohorts

Rather than forcing rapid change, peptides encourage the skin to rebuild itself gradually